Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SAFER

Financiado

Cerrado

Semantic integrAtion and reasoning Framework for pharmacovigilancE signals Resea...

Semantic integrAtion and reasoning Framework for pharmacovigilancE signals Research Adverse drug effects endanger patients’ safety and cause considerable extra healthcare costs. The procedures of drug surveillance and drug harm prevention are studied by pharmacovigilance. Several Information Technology (IT) metho... ver más

30/06/2015

INSERM

270K€

Presupuesto del proyecto: 270K€

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-06-30 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

INSERM

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

kANNa Knowledge graph completion using Artificial Neural Networks... 185K€ Cerrado

PROTECT Pharmacoepidemiolocal Research on Outcomes of Therapeutics b... 29M€ Cerrado

EU-ADR Exploring and understanding adverse drug reactions by integr... 6M€ Cerrado

MELLODDY MachinE Learning Ledger Orchestration for Drug DiscoverY 19M€ Cerrado

MEDIKURA MEDIKURA Digital Infrastructure for Drug Safety in Europe 71K€ Cerrado

eTRANSAFE Enhacing TRANslational SAFEty Assessment through Integrative... 41M€ Cerrado

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 270K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Adverse drug effects endanger patients’ safety and cause considerable extra healthcare costs. The procedures of drug surveillance and drug harm prevention are studied by pharmacovigilance. Several Information Technology (IT) methods are currently employed for conducting research as regards identification of pharmacovigilance signals. The current project (SAFER) will elaborate on exploiting and complementing evidence obtained from various types of existing pharmacovigilance signal sources through: (a) the semantic harmonization and mediation among the respective signal detection methods, and (b) the development of signal aggregation and reasoning mechanisms that will enable knowledge fusion of the obtained outcomes, introducing overall an integrated, semantic approach for obtaining and managing knowledge on pharmacovigilance signals. The proposed approach is particularly applicable, since signal generation is characterized by incomplete knowledge and uncertainty in the results obtained from all types of signal detection methods, thus, a synthesis of all possible signal sources is necessary. SAFER aims to properly detect true associations and minimize false positive findings, which are the major drawbacks of most signal detectors currently available, so as to reinforce the reliability and completeness of pharmacovigilance signals. Major expected results of SAFER constitute: (a) a generic knowledge model that will address the heterogeneity of the available signal detectors via their semantic harmonization, (b) an advanced decision support service for medication error prevention based on the introduced reasoning scheme, and (c) a semantically-enriched IT framework for integrated pharmacovigilance research. SAFER will be conducted in the INSERM - U872, Eq20 - group, a centre of excellence in the field of knowledge engineering and semantic technologies in e-health with major application domain pharmacovigilance.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores